A patient of situs ambiguus with pancreatic head cancer successfully treated with gemcitabine and erlotinib
- PMID: 20094824
- DOI: 10.1007/s12032-010-9421-7
A patient of situs ambiguus with pancreatic head cancer successfully treated with gemcitabine and erlotinib
Abstract
We report a case of a 66-year-old Taiwanese female patient with situs ambiguus diagnosed of pancreatic head cancer. She was treated with gemcitabine and erlotinib and remained in stable disease on follow-up imaging studies. Situs ambiguus is a rare disease and reports of such patients with cancer have rarely been reported in the literature. Our case illustrates that standard chemotherapy in this group of patients may be undergone with promising results.
Similar articles
-
Erlotinib or capecitabine with gemcitabine in pancreatic cancer?Future Oncol. 2006 Apr;2(2):161-3. doi: 10.2217/14796694.2.2.161. Future Oncol. 2006. PMID: 16563084 No abstract available.
-
Pancreatic cancer: an update.Curr Oncol Rep. 2007 May;9(3):170-6. doi: 10.1007/s11912-007-0018-z. Curr Oncol Rep. 2007. PMID: 17430687 Review.
-
Brief communication: a new combination in the treatment of advanced pancreatic cancer.Semin Oncol. 2005 Dec;32(6 Suppl 8):5-6. doi: 10.1053/j.seminoncol.2005.07.017. Semin Oncol. 2005. PMID: 16360004 Clinical Trial.
-
[Efficacy of gemcitabine combined with erlotinib in patients with advanced pancreatic cancer].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Aug;32(4):421-3. doi: 10.3881/j.issn.1000-503X.2010.04.013. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010. PMID: 20868602 Chinese.
-
Novel advances in pancreatic cancer treatment.Expert Rev Anticancer Ther. 2008 Jun;8(6):993-1002. doi: 10.1586/14737140.8.6.993. Expert Rev Anticancer Ther. 2008. PMID: 18533808 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical